UBS Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.2M | Buy |
|
|||||
|
2025
Q1 | $26.1M | Buy |
|
|||||
|
2024
Q4 | $22M | Buy |
|
|||||
|
2024
Q3 | $1.04M | Sell |
|
|||||
|
2024
Q2 | $1.48M | Buy |
|
|||||
|
2024
Q1 | $1.34M | Buy |
|
|||||
|
2023
Q4 | $900K | Buy |
|
|||||
|
2023
Q3 | $795K | Sell |
|
|||||
|
2023
Q2 | $3.3M | Buy |
|
|||||
|
2023
Q1 | $1.36M | Sell |
|
|||||
|
2022
Q4 | $1.81M | Sell |
|
|||||
|
2022
Q3 | $1.61M | Buy |
|
|||||
|
2022
Q2 | $1.6M | Buy |
|
|||||
|
2022
Q1 | $1.52M | Sell |
|
|||||
|
2021
Q4 | $4.23M | Buy |
|
|||||
|
2021
Q3 | $4.44M | Buy |
|
|||||
|
2021
Q2 | $4.28M | Sell |
|
|||||
|
2021
Q1 | $4.88M | Buy |
|
|||||
|
2020
Q4 | $1.83M | Buy |
|
|||||
|
2020
Q3 | $1.49M | Sell |
|
|||||
|
2020
Q2 | $1.56M | Buy |
|
|||||
|
2020
Q1 | $1.09M | Buy |
|
|||||
|
2019
Q4 | $1.41M | Sell |
|
|||||
|
2019
Q3 | $1.28M | Sell |
|
|||||
|
2019
Q2 | $1.56M | Sell |
|
|||||
|
2019
Q1 | $4.58M | Sell |
|
|||||
|
2018
Q4 | $171M | Buy |
|